|
|
Volumn 17, Issue 4 SUPPL., 2003, Pages
|
|
Changing role of induction therapy in solid organ transplantation
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
BASILIXIMAB;
CALCINEURIN INHIBITOR;
DACLIZUMAB;
LYMPHOCYTE ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
OKT 3;
RAPAMYCIN;
STEROID;
THYMOCYTE ANTIBODY;
ARTICLE;
DOSE RESPONSE;
DRUG COST;
DRUG EFFICACY;
DRUG INFUSION;
DRUG SAFETY;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LOW DRUG DOSE;
LYMPHOCYTE DEPLETION;
MAINTENANCE THERAPY;
ORGAN TRANSPLANTATION;
RISK ASSESSMENT;
|
|
EID: 0345530975
PISSN: 0955470X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.trre.2003.07.010 Document Type: Article |
|
Times cited : (1)
|
|
References (0)
|
